Identifying potential toxicity in the early stage of drug discovery can save time and development cost and reduce the possibility of late failure. Hepatotoxicity and cardiotoxicity are the most common toxicity caused by drugs, which is also the main reason for drugs to withdraw from the market. Therefore, predicting the potential toxicity of candidate compounds is very important for drug development. Compared with in vivo toxicity testing, in vitro toxicity testing is considered more useful in the early stage of drug development because of its short turnaround time and relatively low cost. https://www.bioimagingtech.com/drug-toxicity-imaging-analysis.html